Show simple item record

dc.contributor.authorInce, Bahri
dc.contributor.authorGedikbasi, Asuman
dc.contributor.authorOzcan, Muhammed Emin
dc.contributor.authorKaradeli, Hasan Huseyin
dc.contributor.authorAsil, Talip
dc.contributor.authorAltinoz, Meric A.
dc.date.accessioned2021-03-06T11:48:02Z
dc.date.available2021-03-06T11:48:02Z
dc.identifier.citationOzcan M. E. , Ince B., Karadeli H. H. , Gedikbasi A., Asil T., Altinoz M. A. , "Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity", NEUROPSYCHIATRIC DISEASE AND TREATMENT, cilt.12, ss.2033-2038, 2016
dc.identifier.issn1178-2021
dc.identifier.othervv_1032021
dc.identifier.otherav_f0cd59fb-e819-4623-bcec-99898bcb030d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/158011
dc.identifier.urihttps://doi.org/10.2147/ndt.s109954
dc.description.abstractObjective: To define whether minor adult hemoglobin A2 (HbA2, alpha 2 delta 2) exerts any protective activity in multiple sclerosis (MS).
dc.language.isoeng
dc.subjectNöroloji
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleHigher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity
dc.typeMakale
dc.relation.journalNEUROPSYCHIATRIC DISEASE AND TREATMENT
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume12
dc.identifier.startpage2033
dc.identifier.endpage2038
dc.contributor.firstauthorID228917


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record